
This study evaluated the clinical impact of electronic Patient Reported Outcome Measures (EPROMs) as a digital remote monitoring intervention on disease activity, treatment decisions and healthcare resource use in patients with IA. Eight studies were included with 4,473 patients, with seven assessing patients with rheumatoid arthritis. Most studies were at high risk of bias with significant heterogeneity in design. Still, our results suggest an advantage in using EPROM monitoring in patients with IA, with the potential for reducing healthcare resource use without detrimental impact on disease outcomes.
Like
Save
Share